New hope for kids with rare eye tumors: drug combo under trial
NCT ID NCT07378657
First seen Feb 01, 2026 · Last updated Apr 25, 2026 · Updated 5 times
Summary
This study aims to find the best treatment approach for children and teens with orbital lymphatic malformation, a rare eye condition. Researchers will test the safety and effectiveness of the drug sirolimus, with or without injection therapy, in 30 participants aged 1-18. The goal is to shrink the malformation and relieve symptoms while monitoring for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ORBITAL LYMPHATIC MALFORMATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ain Shams University
RECRUITINGCairo, Cairo Governorate, 11321, Egypt
Contact
Contact
Contact Email: •••••@•••••
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.